Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Clinical trial NCT00256282 · COMPLETED

Trial details

NCT number: NCT00256282
Sponsor: John P. Fruehauf
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2003-04-01
Primary completion: 2012-08-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.